接种疫苗

Antigen-presenting cells (APCs) such as dendritic cells engulf vaccine antigens, degrade them, and display antigen pieces on their surface bound to MHC molecules. APCs then migrate to lymph nodes where they stimulate naive helper T cells and cytotoxic T cells. This activation triggers cell-mediated immune responses that prepare the body to recognize and eliminate the pathogen if encountered later.

After activation by helper T cells, B cells differentiate into two types. Plasma cells immediately produce antibodies specific to vaccine antigens that bind to and destroy pathogens. Memory B cells persist in the body for months or years, enabling rapid antibody production upon future exposure to the same pathogen, providing long-term immunity.

Memory T cells and B cells generated during vaccination recognize antigens from previously encountered pathogens. Upon reexposure, these memory cells divide rapidly and mount a quicker, more efficient immune response than the initial vaccination. This accelerated response prevents or reduces disease severity when the actual pathogen is encountered.

Cytotoxic T lymphocytes (CTLs), also called killer T cells, are activated by helper T cells after vaccination. CTLs detect infected cells, bind to them, and release chemicals that kill the cells along with harbored pathogens. This cell-mediated response is crucial for eliminating virus-infected cells and preventing pathogen spread.

Herd immunity occurs when a high percentage of the population is vaccinated against a pathogen, preventing its transmission throughout the community. Even unvaccinated individuals, including those too young or immunocompromised to receive vaccines, have reduced infection risk because the pathogen cannot find sufficient susceptible hosts to propagate.

The influenza virus evolves at an exceptionally rapid rate, with new viral strains emerging frequently. Because existing vaccines target specific viral strains, a new vaccine must be developed each year to match the currently circulating influenza variants and provide effective protection against infection.

Vaccines contain antigens derived from specific pathogens in different forms. Inactive vaccines contain intact but non-replicating antigens, while subunit vaccines contain only pathogen fragments. Attenuated vaccines use live weakened pathogens that stimulate immune responses without causing severe disease, and many vaccines include adjuvants to enhance immune responses.